SOGC/APOG Ontario CME 2017

November 30-December 2, 2017 in Toronto, Ontario

Scientific program is subject to change

Cliquez ici pour le programme en français.

Photo of Jessica  Dy

Biography

Dr. Jessica Dy MD

Ottawa ON
Dr. Jessica Dy received her Bachelor of Science Degree in Honours Physiology from the University of British Columbia (1995) and her medical degree from the University of Western Ontario (1999). She then completed her residency training in Obstetrics and Gynecology at the University of Ottawa and became a Fellow of the Royal College of Physicians and Surgeons of Canada in 2004. She pursued further training in Quantitative Research and Epidemiology and obtained her Master's Degree in Public Health (MPH) at the Harvard School of Public Health (2010).

Dr. Dy has an active obstetrics and gynecology practice in Ottawa and has been Head of the Division of General Obstetrics and Gynecology at The Ottawa Hospital since 2014. She is an Associate Professor at the University of Ottawa where she is actively involved in medical education and training both at the undergraduate and post-graduate level. She is also a volunteer instructor with the Canadian Network of International Surgery.

Dr. Dy's research interests are in labour management, induction of labour, Caesarean sections, quality and patient safety in Obstetrics and Gynecology. She is the principal investigator of a multi-center randomized labour trial on the use of oxytocin in nulliparous women in labour. She is the Vice Chair of Quality and Patient Safety of the Department of Obstetrics, Gynecology and Newborn Care at The Ottawa Hospital and has been instrumental in many practice changes occurring locally. From the bedside and beyond, she has dedicated her career in improving the health outcomes of women and their babies.

Disclosure

I have/had an affiliation (financial or otherwise) with a pharmaceutical, medical device or communications organization:

- I have received a grant(s) or an honorarium from a commercial organization: Ferring Canada

I do intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).